Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bristol-Myers Squibb (BMS)
Scientific Title
A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination With Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants With Advanced Hepatocellular Carcinoma